StockData
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31

Evogene Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$0.37−0.02 (-4.71%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
0.3
Dividend yield
–

Evogene Ltd. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Evogene does not break out revenue by segment, region or product in the tagged data of its filings for this period type.